Anzeige
❌
Mehr »
Mittwoch, 04.11.2026 - Börsentäglich über 12.000 News
Zehn Katalysatoren in vier Monaten und die Rally könnte erst beginnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
13:46Trump's healthcare plans under contention after Democrats' midterm landslide
12:46Boehringer signs oncology deal with Sino Biopharm worth up to $7.4bn
12:46AbbVie bolsters UK R&D presence, inks $1.38bn IBD deal with Nxera
11:46GEBRO and Spektus sign collaboration for ActraFlex
10:46FDA to review uniQure's BLA for Huntington's gene therapy
DiFDA calls for stronger potency upkeep in CGT manufacturing
DiAbbVie inks $757m migraine-focused deal with Brise Pharmaceuticals
DiLonza to acquire five US manufacturing sites from Merck KGaA
DiBavarian Nordic secures four-year UK vaccine supply deal
MoFresenius and WuXi team up in 37-strong biosimilar development deal
MoPelthos and Castle Creek plan merger to target skin diseases
MoInovio's Voceryq receives FDA accelerated approval for RRP
FrCasgevy gains UK label expansion for younger patient population
FrEli Lilly's tirzepatide outperforms big pharma companies in Q3
FrGlenmark opens Allentown distribution hub in US
FrDren Bio raises $350m for dibotatug clinical development
DoRFK Jr backs compounding of six unapproved peptides in new policy
DoUK Budget light on life sciences but more doors open for biotech startups
DoEnthorin and Rumi sign agreement for FXS therapy
DoFormation Bio launches $600m drug development fund
28.10.Ferring bets on Gameto's reproductive health solution through $1.38bn takeover
28.10.Astellas fortifies immuno-oncology pipeline on $1.3bn Audax licensing deal
28.10.FDA grants orphan drug status to Octant's OCT-980 for RP
28.10.Arrowhead gains UK marketing authorisation for Redemplo
28.10.Anthropic plots IPO amid ongoing foray into drug development